Pay in installments of $5.63 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Wegovy Pill Becomes First Oral GLP 1 Weight Loss Drug Approved in U.S. Scientific American Nurx vs SimpleHealth vs Wisp Compared Fin vs Fin Lawsuit filed against makers of Ozempic, Mounjaro over claims of 'gastrointestinal side effects' ABC News How to Inject Semaglutide Simple Step by Step Guide Healthon $43 For a 4 Week Semaglutide Weight Loss Program W Consultation at WeightCare FT. LAUDERDALE, FL Eli Lilly this month unveiled startling new data that showed an experimental weight loss drug caused people with obesity to shed, on average, 28 percent of their body weight a substantial step
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.0 ★★★★★
Based on 8 reviews
Sort
Product Reviews
★★★★★ 5
Complete Edition of Books
Format: Paperback
Really good reading material
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 6, 2026
★★★★★ 5
Felt like opening a long-lost vault
Format: Paperback
I had no idea what I was getting into when I picked this up. These writings are so different from the Bible I grew up with—more mystical, more cosmic, and honestly more human in some parts. The modern English translation helped a lot, because even with that, it takes time to digest. Jubilees really surprised me—it’s like reading Genesis with a behind-the-scenes commentary. And Enoch III? That one goes wild. This book isn’t casual reading, but if you’re spiritually curious or love ancient texts, it opens up a totally different lens on early beliefs.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 24, 2025
★★★★★ 5
Gave me chills more than once
Format: Paperback
I didn’t expect to feel so pulled in, but there were parts of this book that made me stop reading and just sit there. The stories are strange, intense, and full of meaning I’m still trying to wrap my head around. Enoch 1 hit me the hardest—watchers, judgment, hidden knowledge—it all felt ancient and oddly urgent. Having the modern translation helped me connect with the words instead of struggling through them. The notes didn’t get in the way either—they actually made me want to dig deeper.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 20, 2025
★★★★★ 5
Mystical, layered, and thought-provoking
Format: Paperback
This book took me on a serious deep dive. I’ve read Jasher before, but this version gave it new life with clean translation and smart notes. Ina Quant and the Three Jubilees were new to me—and honestly, they pulled me in with their strange, prophetic rhythm. It’s not a casual read, but if you’re spiritually curious or love ancient texts that go beyond the traditional canon, this is a goldmine. It felt like uncovering the other half of a story I didn’t know was incomplete.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 25, 2025
★★★★★ 4
Nice edition
Format: Hardcover
Received in new condition and rather quickly considering the ice and snow in various States. Love the easy to read large print.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 31, 2026
recommand products
The GLP-1 Revolution: How Next-Generation Obesity Drugs Are Reshaping the Global Healthcare Market
24.51
The next phase of the obesity drug race
24.39
GLP-1 Drugs Market Size to Hit USD 132.79 Bn by 2035
22.15
GLP-1s are no longer the "future" of diabetes care. They're the present now that 23% of first-line diabetes treatment are GLP-1s. --- In just five years, GLP-1s have gone from niche second-line… |
25.51
Glucagon-like peptide-1
27.60